Wall Street’s most significant and market-influencing research ratings reports have been compiled. Below are key insights for investors highlighted by The Fly.

Five Stocks with Upgraded Ratings

eBay (stock code: EBAY) JMP Securities, a subsidiary of Citizens Bank, has upgraded eBay’s rating from “In Line with the Market” to “Outperform,” setting a target price of $115. The firm believes that innovations in core categories are creating a “significantly better consumer experience” for eBay, which is expected to drive mid-single-digit growth in merchandise volume by 2026.

Coinbase (stock code: COIN) JPMorgan Chase has raised its rating on Coinbase from “Neutral” to “Overweight,” increasing the target price from $342 to $404. The firm indicated in its report that Coinbase’s current valuation is attractive compared to its peers in the cryptocurrency sector, as the company's profit opportunities are becoming clearer while risks continue to ease.

Tractor Supply (stock code: TSCO) Morgan Stanley has upgraded Tractor Supply’s rating from “Underweight” to “In Line with the Market,” raising the target price from $50 to $60. The institution noted that Tractor Supply has navigated its investment cycle, and its performance metrics are returning to more normalized levels.

AppFolio (stock code: APPF) Keefe Bruyette & Woods has upgraded AppFolio from “In Line with the Market” to “Outperform,” setting a target price of $311. The upgrade is justified by the stock's underperformance of 31% relative to the market since early August and its current valuation being at the lower end of historical P/E ratios. The firm expects recently launched and upcoming AI and tenant service products to drive revenue growth exceeding 20%, a potential not yet fully recognized by the market. Furthermore, the investor day event scheduled for mid-November could serve as a catalyst for stock price movement.

Alliant Energy (stock code: LNT) UBS has raised its rating on Alliant Energy from “Neutral” to “Buy,” with a target price increase from $74 to $79. The firm believes that the company’s load growth, increased capital spending, and coordinated regulatory policies will provide upward price momentum.

Five Stocks with Downgraded Ratings

Molina Healthcare (stock code: MOH) Barclays has downgraded Molina Healthcare from “In Line with the Market” to “Underweight,” with a target price reduction from $185 to $144. The firm considers the initial EPS estimate of $14 for 2026 “too optimistic,” assuming the company’s Medicaid medical loss ratio remains consistent with last year's.

Integer (stock code: ITGR) Wells Fargo has downgraded Integer from “Overweight” to “In Line with the Market,” lowering the target price from $132 to $80. The firm noted that the revised Q4 earnings guidance and 2026 outlook are significantly below Wall Street expectations. Additionally, Bank of America and Benchmark have also downgraded the stock to a neutral level.

Inspire Medical (stock code: INSP) Jefferies has downgraded Inspire Medical from “Buy” to “Hold,” with a target price reduction from $160 to $85. The firm’s research in the U.S. sleep field and interviews with physicians indicate that the stock faces multiple headwinds: the impact of weight loss drugs, increasing market share from competitors, and modest expectations for sales growth of Inspire 5-related products.

Arcturus Therapeutics (stock code: ARCT) H.C. Wainwright has downgraded Arcturus Therapeutics from “Buy” to “Neutral,” reducing the target price from $60 to $12. The firm indicated, based on communications with key opinion leaders regarding interim data from the ARCT-032 Phase 2 clinical trial, that the company's cystic fibrosis treatment project does not warrant progression to late-stage clinical trials.

Plexus (stock code: PLXS) Sidoti has downgraded Plexus from “Buy” to “Neutral,” setting a target price of $150. While the firm noted the company’s Q4 earnings are “solid,” due to macroeconomic uncertainties and management's commentary, they have prudently adjusted their earnings expectations for FY 2026 and FY 2027.

Five Newly Covered Stocks

Amazon (stock code: AMZN) KeyBanc has restored coverage of Amazon with an “Overweight” rating and a target price of $300. The firm stated that advertising is driving growth in Amazon's retail division, paving the way for grocery to become a more significant revenue pillar in the medium term.

DoorDash (stock code: DASH) Barclays has resumed coverage on DoorDash following its acquisition of Deliveroo, granting it a “Market Perform” rating with a target price of $272. The firm noted that DoorDash’s stock price has partially reflected “bullish logic,” but it remains optimistic about its “bright prospects.”

Legence (stock code: LGN) Roth Capital has initiated coverage of Legence with a “Buy” rating and a target price of $41. The firm pointed out that Legence benefits from the development dividends in the energy-efficient infrastructure sector, particularly in high-tech data centers and the life sciences industry, which accounts for 50% of the company’s unfilled orders.

Novavax (stock code: NVAX) Cantor Fitzgerald has initiated coverage of Novavax with an “Overweight” rating and a target price of $18. The firm introduced the company, known for developing the Nuvaxovid vaccine, as having shifted from a commercialization model to an authorization model, seeking partnerships around new vaccine candidates and Matrix-M technology for substantial upfront payments, milestone payments, royalties, and revenue.

Tennant (stock code: TNC) Roth Capital has initiated coverage of Tennant with a “Buy” rating and a target price of $102. The firm believes that in the $9 billion mechanized cleaning market, Tennant has the potential to increase its median market share with multiple catalysts. The report noted that Tennant possesses a “differentiated” product portfolio (including autonomous cleaning equipment) and an “unmatched service system,” providing a lasting competitive advantage and the ability to seize market opportunities.